Global Rapid Influenza Diagnostic Test (RIDT) Market Size, Status and Forecast 2020-2026

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
The classification of Rapid Influenza Diagnostic Test (RIDT) includes Conventional RIDT and Digital RIDTs. The proportion of digital RIDTs in 2018 is about 53.35% of revenue.Rapid Influenza Diagnostic Test (RIDT) is application in hospital, POCT and others. The most of Rapid Influenza Diagnostic Test (RIDT) is used in hospital, and the market share of that is about 63.97% in 2018.North America is the largest consumption place, with a consumption market share nearly 53.65% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 26.27% in 2018.

Market competition is intense. BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics) are the leaders of the industry, and have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Rapid Influenza Diagnostic Test (RIDT) Market
In 2019, the global Rapid Influenza Diagnostic Test (RIDT) market size was US$ 1066.3 million and it is expected to reach US$ 1924.2 million by the end of 2026, with a CAGR of 8.7% during 2021-2026.
Global Rapid Influenza Diagnostic Test (RIDT) Scope and Market Size
Rapid Influenza Diagnostic Test (RIDT) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Influenza Diagnostic Test (RIDT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Rapid Influenza Diagnostic Test (RIDT) market is segmented into Digital RIDTs, Conventional RIDT, etc.
Segment by Application, the Rapid Influenza Diagnostic Test (RIDT) market is segmented into Hospitals, POCT, Others, etc.
Regional and Country-level Analysis
The Rapid Influenza Diagnostic Test (RIDT) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rapid Influenza Diagnostic Test (RIDT) market report are North America and Europe., etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Rapid Influenza Diagnostic Test (RIDT) Market Share Analysis
Rapid Influenza Diagnostic Test (RIDT) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Rapid Influenza Diagnostic Test (RIDT) business, the date to enter into the Rapid Influenza Diagnostic Test (RIDT) market, Rapid Influenza Diagnostic Test (RIDT) product introduction, recent developments, etc.
The major vendors include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), etc.

This report focuses on the global Rapid Influenza Diagnostic Test (RIDT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid Influenza Diagnostic Test (RIDT) development in North America and Europe..

The key players covered in this study

BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)

Market segment by Type, the product can be split into

Digital RIDTs
Conventional RIDT
In 2018, Digital RIDTs accounted for a major share of 55.36% the global Rapid Influenza Diagnostic Test (RIDT) market. And this product segment is poised to reach 1039.09 million US$ by 2025 from 588.84 million US$ in 2018.

Market segment by Application, split into

Hospitals
POCT
Others
In Rapid Influenza Diagnostic Test (RIDT) market, the Hospitals holds an important share in terms of application, and it is expected to reach revenue of by 2025, at a CAGR of 8.37% during 2019 and 2025.

Market segment by Regions/Countries, this report covers

North America
Europe

The study objectives of this report are:

To analyze global Rapid Influenza Diagnostic Test (RIDT) status, future forecast, growth opportunity, key market and key players.
To present the Rapid Influenza Diagnostic Test (RIDT) development in North America and Europe..
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Rapid Influenza Diagnostic Test (RIDT) are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.